erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
pmid:
Kawase M et al. In vitro susceptibility of Helicobacter pylori to trifluoromethyl ketones. 1999 Bioorg. Med. Chem. Lett. pmid:10021926
Tomomasa T et al. Gastrointestinal sounds and migrating motor complex in fasted humans. 1999 Am. J. Gastroenterol. pmid:10022632
Nissan A et al. A direct inhibitory effect of erythromycin on rat urinary bladder smooth muscle. 1999 J. Urol. pmid:10022741
Woolverton CJ et al. Subverting bacterial resistance using high dose, low solubility antibiotics in fibrin. 1999 Jan-Feb Infection pmid:10027103
Hansen LH et al. The macrolide-ketolide antibiotic binding site is formed by structures in domains II and V of 23S ribosomal RNA. 1999 Mol. Microbiol. pmid:10027978
Xiong L et al. A ketolide resistance mutation in domain II of 23S rRNA reveals the proximity of hairpin 35 to the peptidyl transferase centre. 1999 Mol. Microbiol. pmid:10027979
Idu SR et al. [A very serious course of psittacosis in pregnancy]. 1998 Ned Tijdschr Geneeskd pmid:10028357
Hirsch R et al. Occurrence of antibiotics in the aquatic environment. 1999 Sci. Total Environ. pmid:10028708
Rediske AM et al. Reducing bacterial resistance to antibiotics with ultrasound. 1999 Lett. Appl. Microbiol. pmid:10030038
Criteria and techniques for the diagnosis of early syphilis-revised recommended treatment schedules. 1976 J Iowa Med Soc pmid:1003017
Anandatheerthavarada HK et al. Physiological role of the N-terminal processed P4501A1 targeted to mitochondria in erythromycin metabolism and reversal of erythromycin-mediated inhibition of mitochondrial protein synthesis. 1999 J. Biol. Chem. pmid:10037757
Sturmberg JP and Watt P Could it be whooping cough? 1999 Aust Fam Physician pmid:10048250
Wubbel L et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. 1999 Pediatr. Infect. Dis. J. pmid:10048679
McDaniel R et al. Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel "unnatural" natural products. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10051557
Miyajima M et al. Effects of erythromycin on experimental extrinsic allergic alveolitis. 1999 Clin. Exp. Allergy pmid:10051731
Klugman KP et al. Increased activity of 16-membered lactone ring macrolides against erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae: characterization of South African isolates. 1998 J. Antimicrob. Chemother. pmid:10052895
Gump DW and Hawley HB Severe Mycoplasma pneumoniae pneumonia. 1976 Respiration pmid:1005941
Furness JB et al. An action of erythromycin in the intestine that is not mediated via motilin receptors. 1999 Clin. Exp. Pharmacol. Physiol. pmid:10065328
Tsang KW et al. A pilot study of low-dose erythromycin in bronchiectasis. 1999 Eur. Respir. J. pmid:10065682
Dordick JS et al. The evolution of biotransformation technologies. 1998 Curr. Opin. Microbiol. pmid:10066492
Nielsen J The role of metabolic engineering in the production of secondary metabolites. 1998 Curr. Opin. Microbiol. pmid:10066494
García de Lomas J et al. [Sensitivity of group A beta-hemolytic Streptococcus isolated from pediatric pharyngotonsillitis to erythromycin and clarithromycin: a primary care multicenter study]. 1999 Enferm. Infecc. Microbiol. Clin. pmid:10069109
Manna PK and Basu SK Studies of erythromycin maltobionate, a new derivative of erythromycin. 1999 Drug Dev Ind Pharm pmid:10071836
Lu W et al. [Analysis of 37 cases of pneumonia of Legionnaires' disease]. 1997 Zhonghua Jie He He Hu Xi Za Zhi pmid:10072832
Hsueh PR et al. Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in Taiwan. 1999 J. Clin. Microbiol. pmid:10074498
Cline MS et al. Bacillary angiomatosis in a renal transplant recipient. 1999 Transplantation pmid:10075597
Collard JM et al. Erythromycin enhances early postoperative contractility of the denervated whole stomach as an esophageal substitute. 1999 Ann. Surg. pmid:10077045
Periti P and Mazzei T Clarithromycin: pharmacokinetic and pharmacodynamic interrelationships and dosage regimen. 1999 J Chemother pmid:10078776
DiBaise JK and Quigley EM Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one center's experience. 1999 J. Clin. Gastroenterol. pmid:10078820
Horn S et al. Cholestasis and liver cell damage due to hypersensitivity to erythromycin stearate--recurrence following therapy with erythromycin succinate. 1999 Wien. Klin. Wochenschr. pmid:10081126
Clark MJ et al. Erythromycin derivatives ABT 229 and GM 611 act on motilin receptors in the rabbit duodenum. 1999 Clin. Exp. Pharmacol. Physiol. pmid:10081621
Iordănescu S Three distinct plasmids originating in the same Staphylococcus aureus strain. 1976 Jan-Jun Arch Roum Pathol Exp Microbiol pmid:1008685
Sagara H [Campylobacter enteritis]. 1999 Ryoikibetsu Shokogun Shirizu pmid:10088324
Nakata K [Diffuse panbronchiolitis (DPB)]. 1999 Ryoikibetsu Shokogun Shirizu pmid:10088434
Zweers-Zeilmaker WM et al. In vitro complex formation and inhibition of hepatic cytochrome P450 activity by different macrolides and tiamulin in goats and cattle. 1999 Res. Vet. Sci. pmid:10088712
Suzuki H et al. Inhibitory effect of erythromycin on interleukin-8 secretion from exudative cells in the nasal discharge of patients with chronic sinusitis. 1999 Laryngoscope pmid:10089966
Stacey A and Bradlow A Arcanobacterium haemolyticum and Mycoplasma pneumoniae co-infection. 1999 J. Infect. pmid:10090506
Sunazuka T et al. Effects of erythromycin and its derivatives on interleukin-8 release by human bronchial epithelial cell line BEAS-2B cells. 1999 J. Antibiot. pmid:10092202
Nieuwenhuijs VB et al. The effects of ABT-229 and octreotide on interdigestive small bowel motility, bacterial overgrowth and bacterial translocation in rats. 1999 Eur. J. Clin. Invest. pmid:10092986
Baron GS and Nano FE An erythromycin resistance cassette and mini-transposon for constructing transcriptional fusions to cat. 1999 Gene pmid:10095104
Enomoto F et al. Effect of erythromycin on otitis media with effusion in experimental rat model. 1998 Acta Otolaryngol Suppl pmid:10095863
Fluhr JW et al. In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa. 1999 Zentralbl. Bakteriol. pmid:10096167
Gates PJ et al. Structural elucidation studies of erythromycins by electrospray tandem mass spectrometry. 1999 Rapid Commun. Mass Spectrom. pmid:10097401
Neaverson MA Intravenous administration of erythromycin: serum, sputum and urine levels. 1976 Curr Med Res Opin pmid:1009781
Provencher SJ et al. Effect of cyclosporine A on cytochrome P-450-mediated drug metabolism in the partially hepatectomized rat. 1999 Drug Metab. Dispos. pmid:10101139
Roddis MJ Antibiotic-associated colitis: a retrospective study of fifteen cases. 1978 Age Ageing pmid:101026
Moss AA et al. Radiologic and clinical assessment of broad-spectrum antibiotic therapy in Crohn's disease. 1978 AJR Am J Roentgenol pmid:101028
Kohyama T et al. Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. 1999 Antimicrob. Agents Chemother. pmid:10103198
Stickney RH et al. Chlamydia trachomatis: a cause of an infantile pneumonia syndrome. 1978 AJR Am J Roentgenol pmid:101061
Elliott WC Treatment of primary syphilis. 1976 J Am Vener Dis Assoc pmid:1010777
Thompson SE Treatment of syphilis in pregnancy. 1976 J Am Vener Dis Assoc pmid:1010783
Budell JW Treatment of congenital syphilis. 1976 J Am Vener Dis Assoc pmid:1010784
Willeit A et al. [Personal experience with erythromycin in the treatment of respiratory tract infections]. 1976 Minerva Pediatr. pmid:1012219
Parikov VA et al. [Effectiveness of antimastitis preparations]. 1976 Veterinariia pmid:1014354
Boelaert J Importance of side effects in treating impetigo. 1992 Pharmacoeconomics pmid:10147114
Ruczaj D and Rambaud J [Erythromycin polymorphism]. 1976 Acta Pol Pharm pmid:1015336
Khosla SN and Khosla P Therapeutic evaluation of various drugs in giardiasis (a comparative trial). 1978 Mod Med Asia pmid:101765
Marra CA et al. Chlamydia trachomatis in adolescents and adults. Clinical and economic implications. 1998 Pharmacoeconomics pmid:10178647
Hofstetter A and Blenk H [Therapy of prostato-vesiculitis]. 1978 MMW Munch Med Wochenschr pmid:101836
Karlsson M et al. Genetic basis of macrolide and lincosamide resistance in Brachyspira (Serpulina) hyodysenteriae. 1999 FEMS Microbiol. Lett. pmid:10188254
Kinirons MT et al. Effects of ketoconazole on the erythromycin breath test and the dapsone recovery ratio. 1999 Br J Clin Pharmacol pmid:10190659
Mthwalo M et al. Antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Lesotho. 1998 Bull. World Health Organ. pmid:10191560
Isohanni MH et al. Effect of erythromycin and itraconazole on the pharmacokinetics of oral lignocaine. 1999 Pharmacol. Toxicol. pmid:10193676
Stenson BJ et al. Influence of erythromycin on establishment of feeding in preterm infants: observations from a randomised controlled trial. 1998 Arch. Dis. Child. Fetal Neonatal Ed. pmid:10194995
Dorner S and Barta A Probing ribosome structure by europium-induced RNA cleavage. 1999 Biol. Chem. pmid:10195431
Montenez JP et al. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. 1999 Toxicol. Appl. Pharmacol. pmid:10198278
Sakaeva DD and Lazareva DN [The effect of erythromycin on immunity in immunodeficiency]. 1999 Jan-Feb Eksp Klin Farmakol pmid:10198768
Jarrett F et al. Antibiotic bowel preparation and burn wound colonization. 1976 Surg Forum pmid:1019996
Scarpignato C and Pelosini I Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility. 1999 Can. J. Gastroenterol. pmid:10202210
Hall JA and Washabau RJ Diagnosis and treatment of gastric motility disorders. 1999 Vet. Clin. North Am. Small Anim. Pract. pmid:10202795
Vasil'ev TV et al. [Immediate results of treatment of syphilis with erythromycin simultaneously with bismuth preparations]. 1976 Vestn Dermatol Venerol pmid:1020453
MiliavskiÄ­ AI and Kostenko AM [Early prevention of syphilis (experimental study)]. 1976 Vestn Dermatol Venerol pmid:1020461
Sefton AM Macrolides and changes in the oral flora. 1999 Int. J. Antimicrob. Agents pmid:10204636
Vermeulen B et al. The formulation and stability of erythromycin-benzoyl peroxide in a topical gel. 1999 Int J Pharm pmid:10205634
Vyhnálek J [Distribution of erythromycin following intramuscular administration in laboratory animals]. 1978 Vet Med (Praha) pmid:102070
Mishra A et al. The effects of erythromycin on the electrocardiogram. 1999 Chest pmid:10208196
Imshenetskaia VF [Erythromycin penetration into the cerebrospinal fluid of patients]. 1976 Antibiotiki pmid:1020930
Burstin PP and Marshall CL Infectious mononucleosis and bilateral peritonsillar abscesses resulting in airway obstruction. 1998 J Laryngol Otol pmid:10209619
Tarsi R and Vitali C [Erythromycin: serum and urine levels following rectal administration (author's transl)]. 1976 Jul-Aug Ann Sclavo pmid:1020971
Lakritz J et al. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration. 1999 Am. J. Vet. Res. pmid:10211682
McConnell SA and Amsden GW Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin. 1999 Pharmacotherapy pmid:10212011
Betriu C et al. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study. 1999 Diagn. Microbiol. Infect. Dis. pmid:10212752
Dubois J and St-Pierre C In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species. 1999 Diagn. Microbiol. Infect. Dis. pmid:10212753
Biedenbach DJ et al. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results. 1999 Diagn. Microbiol. Infect. Dis. pmid:10212755
Kim RB et al. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. 1999 Pharm. Res. pmid:10213372
Torii A [Effective treatment in combination with erythromycin and cisapride for chronic idiopathic intestinal pseudo-obstruction (CIIP)]. 1999 Nihon Shokakibyo Gakkai Zasshi pmid:10214084
Bercault N and Linassier P [The value of sepsis isolation to diminish the spread of multidrug-resistant bacteria in intensive care. Consequences on the incidence of nosocomial infections]. 1999 Rev Med Interne pmid:10220829
Perez-Trallero E et al. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. 1999 Mar-Apr Emerging Infect. Dis. pmid:10221875
Jackson LA et al. Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline. 1999 Mar-Apr Emerging Infect. Dis. pmid:10221884
Bassetti M et al. Streptococcus pyogenes erythromycin resistance in Italy. 1999 Mar-Apr Emerging Infect. Dis. pmid:10221991
Siedlik PH et al. Erythromycin coadministration increases plasma atorvastatin concentrations. 1999 J Clin Pharmacol pmid:10234598
Tran JQ et al. Assessment of the potential pharmacokinetic and pharmacodynamic interactions between erythromycin and argatroban. 1999 J Clin Pharmacol pmid:10234600
Morris LA and Kanouse DE Consumer reactions to differing amounts of written drug information. 1980 Jul-Aug Drug Intell Clin Pharm pmid:10247887
Bystedt H et al. Concentrations of azidocillin, erythromycin, doxycycline and clindamycin in human mandibular bone. 1978 Int J Oral Surg pmid:102599
Klein JO Middle ear disease in children. 1976 Hosp Pract pmid:1026633
Gregotti C et al. [Effects of phenobarbital on the hepatic microsome metabolism of erythromycin in rats]. 1976 Boll. Soc. Ital. Biol. Sper. pmid:1027460
Melon J and Reginster M [Passage into normal salivary, lacrimal and nasal secretions of ampicillin and erythromycin administered intramuscularly]. 1976 Acta Otorhinolaryngol Belg pmid:1028340
Rosenthal AL et al. Polyacrylic bone cement containing erythromycin and colistin. I. In vitro bacteriological activity and diffusion properties of erythromycin, colistin and erythromycin/colistin comibination. 1976 J. Int. Med. Res. pmid:1028631
Stille W [Legionnaire's disease]. 1978 MMW Munch Med Wochenschr pmid:102952